Search Result "MEK/ERK"
Recent Developments in Anti-Cancer Agents Targeting the Ras/Raf/ MEK/ERK Pathway
Journal: Recent Patents on Anti-Cancer Drug Discovery
Volume: 4 Issue: 1 Year: 2009 Page: 28-35
Author(s): Kwong-Kwok Wong
Back to the Bench? MEK and ERK Inhibitors for the Treatment of KRAS Mutant Lung Adenocarcinoma
Journal: Current Medicinal Chemistry
Volume: 25 Issue: 5 Year: 2018 Page: 558-574
Author(s): Jens Kohler,Marco Catalano,Chiara Ambrogio
EGF/EGFR Promotes Salivary Adenoid Cystic Carcinoma Cell MalignantNeural Invasion via Activation of PI3K/AKT and MEK/ERK Signaling
Journal: Current Cancer Drug Targets
Volume: 22 Issue: 7 Year: 2022 Page: 603-616
Author(s):
The Therapeutic Promise of Anti-Cancer Drugs Against the Ras/Raf/MEK/ERK Pathway
Ebook: Topics in Anti-Cancer Research
Volume: 2 Year: 2013
Author(s): Erin K. Crane,Kwong-Kwok Wong
Doi: 10.2174/9781608051366113020006
Non-canonical Small GTPase RBJ Promotes NSCLC Progression Through theCanonical MEK/ERK Signaling Pathway
Journal: Current Pharmaceutical Design
Volume: 28 Issue: 42 Year: 2022 Page: 3446-3455
Author(s):
Ligustrazine Suppresses the Growth of HRPC Cells through the Inhibition of Cap- Dependent Translation Via Both the mTOR and the MEK/ERK Pathways
Journal: Anti-Cancer Agents in Medicinal Chemistry
Volume: 15 Issue: 6 Year: 2015 Page: 764-772
Author(s): Jiaoyan Han,Jiao Song,Xiangyun Li,Ming Zhu,Wei Guo,Wei Xing,Rongshen Zhao,Xiao He,Xiaoping Liu,Shali Wang,Yunyun Li,Hong Huang,Xiang Xu
Aesculetin Inhibits Proliferation and Induces Mitochondrial Apoptosis in BladderCancer Cells by Suppressing the MEK/ERK Signaling Pathway
Journal: Anti-Cancer Agents in Medicinal Chemistry
Volume: 23 Issue: 4 Year: 2023 Page: 478-487
Author(s):
Signaling Through RAS-RAF-MEK-ERK: from Basics to Bedside
Journal: Current Medicinal Chemistry
Volume: 14 Issue: 5 Year: 2007 Page: 601-623
Author(s): Armin Zebisch, Armin P. Czernilofsky, Gyorgy Keri, Julja Smigelskaite, Heinz Sill, Jakob Troppmair
The Treatment of Tubal Inflammatory Infertility using Yinjia Tabletsthrough EGFR/MEK/ERK Signaling Pathway based on NetworkPharmacology
Journal: Current Pharmaceutical Biotechnology
Volume: 25 Issue: 4 Year: 2024 Page: 499-509
Author(s):
Ruscogenin Alleviates Deep Venous Thrombosis and Pulmonary Embolism Inducedby Inferior Vena Cava Stenosis Inhibiting MEK/ERK/Egr-1/TF Signaling Pathwayin Mice
Journal: Current Pharmaceutical Design
Volume: 28 Issue: 24 Year: 2022 Page: 2001-2009
Author(s):